Central Lab Market

Central Lab Market (Product: Genetic Services, Biomarker Services, Microbiology Services, Anatomic Pathology/Histology, Specimen Management & Storage, Special Chemistry Services, Clinical Research & Trial Services, and Others) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2023-2031

Global Central Lab Market Outlook 2031

  • The global industry was valued at US$ 2.6 Bn in 2022
  • It is projected to grow at a CAGR of 5.1% from 2023 to 2031 to reach more than US$ 4.1 Bn by 2031

Analysts’ Viewpoint

Increase in demand for personalized medicines and rise in number of clinical trials are the key factors boosting central lab market development. Surge in prevalence of chronic diseases such as diabetes and cancer and growth in need for accurate and reliable diagnostic services are also fueling central lab market dynamics.

Adoption of advanced technologies, such as automation and Artificial Intelligence, is expected to drive central lab industry growth in the next few years. However, high cost of central lab services and lack of skilled professionals are likely to restrain market growth to some extent. Key players operating in the global market are focusing on strategic collaborations and partnerships to enhance product offerings and expand their global footprint.

Central Lab Market

Market Introduction

Central diagnostic laboratory is a vital component of the healthcare industry, as it provides essential services to pharmaceutical and biotech companies. Central labs are specialized facilities that offer a range of services, including clinical trial testing, biomarker analysis, and drug development support. These labs are equipped with advanced technologies and highly skilled professionals who work together to provide accurate and reliable results.

Central laboratory services include bioanalytical testing, clinical chemistry, hematology, microbiology, and molecular diagnostics. These services are essential for drug development and clinical trials, as they help identify potential safety issues and ensure the efficacy of new drugs.

Central labs offer a range of advantages, including standardized testing protocols, centralized data management, and faster turnaround times.

Increase in Demand for Clinical Trials to Fuel Market Expansion

Clinical trials are an essential part of drug development. Central labs provide various services such as sample collection, testing, analysis, and reporting to support clinical trial activities.

The global central lab business is growing at a rapid pace due to the increase in prevalence of chronic diseases and rise in aging population. As a result, demand for new drugs that help treat these diseases effectively is rising significantly. This has led to an increase in number of clinical trials being conducted globally.

Regulatory organizations of different countries have made it mandatory for pharmaceutical companies to conduct extensive clinical trials before launching any new drug in the market. Such regulations ensure that drugs are safe and effective before they reach patients.

Central labs play a crucial role in supporting these clinical trials by providing accurate and reliable data on drug efficacy and safety. They help pharmaceutical companies meet regulatory requirements while ensuring patient safety.

Advancements in technologies, such as electronic data capture (EDC) systems and cloud-based platforms, have allowed central labs to offer more efficient services at lower costs than traditional methods. This has further increased their popularity among pharmaceutical companies conducting clinical trials.

Growth in Adoption of Personalized Medicines Augmenting Market Progress

Personalized medicine involves offering medical treatment based on a patient’s genetic information. Personalized medicine offers several benefits over traditional approaches such as improved treatment outcomes with fewer side effects, which lead to a better quality of life for patients suffering from chronic conditions.

Personalized medicine also reduces healthcare costs through targeted therapies, which help reduce unnecessary treatments or hospitalizations.

Central labs play a key role in supporting personalized medicines by providing accurate and reliable data on patient characteristics such as genetics, biomarkers, and other diagnostic tests. This information is used to develop targeted therapies that are more effective than traditional approaches.

Rise in prevalence of chronic diseases such as cancer and diabetes has boosted the demand for personalized medicines. According to the World Health Organization (WHO), cancer is one of the leading causes of death across the globe. Personalized medicines offer hope for better treatment outcomes for these patients.

High Demand for Genetic Services Offered by Central Labs

The genetic services product segment accounted for significant market share in 2022. It is expected to dominate in the near future. Increase in demand for personalized medicines is one of the key factors driving the segment.

Advancements in technology have made genetic testing faster and more affordable. For instance, Illumina, Inc., a leading provider of DNA sequencing technology, announced the launch of its new NovaSeq 6000 Sequencing System in January 2017. The system can sequence up to 48 human genomes per run at a lower cost than previous systems.

Such technological advancements have enabled central labs to offer genetic testing services at competitive prices, thereby boosting central lab market growth.

Pharmaceutical Companies Striving to Reduce Development Cost of New Drugs

The pharmaceutical companies end-user segment is estimated to account for major share of the global market in the near future. Pharmaceutical companies are taking efforts to reduce the cost of development and manufacture of drugs.

Central lab services can be outsourced by these companies. Central lab services provide advanced technologies and use innovative processes. This helps in the drug development process. Central labs also prove more efficient and cost-effective for large multinational pharmaceutical companies in lowering the development cost of new drugs.

Regional Outlook of Global Central Lab Industry

North America is anticipated to dominate the global central lab market during the forecast period, owing to the presence of well-established pharmaceutical companies and high adoption rate of advanced technologies.

Presence of leading players such as Laboratory Corporation of America Holdings (Labcorp), Quest Diagnostics, and Charles River Laboratories International, Inc. is also fueling market statistics in North America. The central lab market size in the region is projected to increase steadily in the next few years, owing to the favorable government initiatives aimed at improving healthcare facilities.

As per the latest central lab market forecast, Asia Pacific is likely to be one of the fastest-growing regions during the forecast period. This growth can be ascribed to the increase in investment by key players in the healthcare sector and rise in demand for clinical trials in the region.

Increase in population and rise in prevalence of chronic diseases in countries such as China and India are projected to fuel central lab market demand in Asia Pacific. Furthermore, low labor costs make it easier for companies to set up operations in the region.

Analysis of Key Players

The global landscape is fragmented, with the presence of several prominent companies that control majority of the central lab market share.

As per the central lab market research analysis, companies are focusing on strategies such as launch of new products, mergers & acquisitions (M&A), and partnerships to strengthen their position in the industry.

ACM Global Laboratories, Bioscientia (Sonic Healthcare), CIRION BioPharma Research, Eurofins Central Laboratory, ICON Central Laboratories, InVitro International, INTERLAB Central Lab Services, Labcorp/Covance, Medpace, PPD, MLM Medical Labs GmbH, Frontage Laboratories, Inc., Barc Lab (Cerba Research), Q² Solutions, Celerion, Clinical Reference Laboratory, and LabConnect are the leading central lab companies operating in this market.

Key Developments

  • In September 2022, MLM Medical Labs GmbH expanded its capacity for storing biological samples at its facilities in Memphis, TN, and Mönchengladbach, Germany. MLM offers biological sample management services for as little as a few days to more than 20 years at all temperature ranges, including ultra-low temperatures to -80°C and in liquid nitrogen (-196°C).
  • In February 2022, Labcorp/Covance, a leading global life sciences organization, announced the inauguration of its new diagnostics laboratory in South Bend, the U.S. This advanced laboratory helps improve service levels and offerings to physicians and patients in South Bend and across the U.S.
  • In October 2021, Labcorp announced the expansion of its bioanalytical services with an integrated central laboratory in Singapore. The laboratory features new capabilities that improve the array of bioanalytical services offered through Labcorp Drug Development. The move is likely to enable the company to cater to the rising demand of several pharmaceutical and biotechnology firms.

Each of these players has been profiled in the central lab market report based on parameters such as financial overview company overview, latest developments, business strategies, business segments, and product portfolio.

Market Snapshot

Attribute

Detail

Market Value in 2022

US$ 2.6 Bn

Market Forecast Value in 2031

More than US$ 4.1 Bn

Compound Annual Growth Rate (CAGR)

5.1%

Forecast Period

2023-2031

Historical Data Available for

2017-2021

Quantitative Units

US$ Bn for Value

Market Analysis

It includes segment analysis as well as regional level analysis. Moreover, qualitative analysis includes drivers, restraints, opportunities, key trends, and parent industry overview.

Competition Landscape

  • Market share analysis/ranking by company (2022)
  • Company profiles section includes overview, product portfolio, key subsidiaries or distributors, strategy & recent developments, and key financials

Format

Electronic (PDF) + Excel

Market Segmentation

  • Product
    • Genetic Services
    • Biomarker Services
    • Microbiology Services
    • Anatomic Pathology / Histology
    • Specimen Management & Storage
    • Special Chemistry Services
    • Clinical Research & Trial Services
    • Others
  • End-user
    • Pharmaceutical Companies
    • Biotechnology Companies
    • Academic & Research Institutes

Regions Covered

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East & Africa

Countries Covered

  • U.S.
  • Canada
  • Germany
  • U.K.
  • France
  • Italy
  • Spain
  • China
  • India
  • Japan
  • Australia & New Zealand
  • Brazil
  • Mexico
  • GCC Countries
  • South Africa

Companies Profiled

  • ACM Global Laboratories
  • Barc Lab (Cerba Research)
  • Bioscientia (Sonic Healthcare)
  • Celerion
  • CIRION BioPharma Research
  • Clinical Reference Laboratory
  • Eurofins Central Laboratory
  • Frontage Laboratories, Inc.
  • ICON Central Laboratories
  • INTERLAB Central Lab Services
  • InVitro International
  • Labcorp/Covance
  • LabConnect
  • Medpace
  • MLM Medical Labs GmbH
  • PPD
  • Q² Solutions

Customization Scope

Available upon request

Pricing

Available upon request

Frequently Asked Questions

How big was the global central lab market in 2022?

It was valued at US$ 2.6 Bn in 2022

How big will the central lab industry be by 2031?

It is projected to reach more than US$ 4.1 Bn by 2031

What will be the CAGR of the central lab business during the forecast period (2031–2031)?

It is anticipated to grow at a CAGR of 5.1% from 2023 to 2031

What are the prominent factors that are driving the demand for central labs?

Increase in complexity and number of clinical trials and rise in focus of companies on minimizing developmental cost of drugs

Which product segment accounted for major share of central labs in 2022?

The genetic services product segment accounted for major share in 2022

Which region is more lucrative for central labs?

North America is the most lucrative region

Who are the prominent players in the central lab sector?

ACM Global Laboratories, Barc Lab (Cerba Research), Bioscientia (Sonic Healthcare), Celerion, CIRION BioPharma Research, Clinical Reference Laboratory, Eurofins Central Laboratory, Frontage Laboratories, Inc., ICON Central Laboratories, INTERLAB Central Lab Services, InVitro International, Labcorp/Covance, LabConnect, Medpace, MLM Medical Labs GmbH., PPD, and Q² Solutions

    1. Preface

        1.1. Market Definition and Scope

        1.2. Market Segmentation

        1.3. Key Research Objectives

        1.4. Research Highlights

    2. Assumptions and Research Methodology

    3. Executive Summary : Global Central Lab Market

    4. Market Overview

        4.1. Introduction

            4.1.1. Product Definition

            4.1.2. Industry Evolution / Developments

        4.2. Overview

        4.3. Market Dynamics

            4.3.1. Drivers

            4.3.2. Restraints

            4.3.3. Opportunities

        4.4. Global Central Lab Market Analysis and Forecast, 2017 - 2031

    5. Key Insights

        5.1. Strategies Adopted by Top 3 Players

        5.2. Impact of Cell and Gene Therapy on Central Lab Market

        5.3. Impact of Clinical Trial on Central Lab Market

        5.4. COVID-19 Impact Analysis

    6. Global Central Lab Market Analysis and Forecast, By Product

        6.1. Introduction & Definition

        6.2. Key Findings / Developments

        6.3. Market Value Forecast By Product, 2017 - 2031

            6.3.1. Genetic Services

            6.3.2. Biomarker Services

            6.3.3. Microbiology Services

            6.3.4. Anatomic Pathology/Histology

            6.3.5. Specimen Management & Storage

            6.3.6. Special Chemistry Services

            6.3.7. Clinical Research & Trial Services

            6.3.8. Others

        6.4. Market Attractiveness By Product

    7. Global Central Lab Market Analysis and Forecast, By End-user

        7.1. Introduction & Definition

        7.2. Key Findings / Developments

        7.3. Market Value Forecast By End-user, 2017 - 2031

            7.3.1. Pharmaceutical Companies

            7.3.2. Biotechnology Companies

            7.3.3. Academic & Research Institutes

        7.4. Market Attractiveness By End-user

    8. Global Central Lab Market Analysis and Forecast, By Region

        8.1. Key Findings

        8.2. Market Value Forecast By Region

            8.2.1. North America

            8.2.2. Europe

            8.2.3. Asia Pacific

            8.2.4. Latin America

            8.2.5. Middle East & Africa

        8.3. Market Attractiveness By Country/Region

    9. North America Central Lab Market Analysis and Forecast

        9.1. Introduction

            9.1.1. Key Findings

        9.2. Market Value Forecast By Product, 2017 - 2031

            9.2.1. Genetic Services

            9.2.2. Biomarker Services

            9.2.3. Microbiology Services

            9.2.4. Anatomic Pathology/Histology

            9.2.5. Specimen Management & Storage

            9.2.6. Special Chemistry Services

            9.2.7. Clinical Research & Trial Services

            9.2.8. Others

        9.3. Market Value Forecast By End-user, 2017 - 2031

            9.3.1. Pharmaceutical Companies

            9.3.2. Biotechnology Companies

            9.3.3. Academic & Research Institutes

        9.4. Market Value Forecast By Country, 2017 - 2031

            9.4.1. U.S.

            9.4.2. Canada

        9.5. Market Attractiveness Analysis

            9.5.1. By Product

            9.5.2. By End-user

            9.5.3. By Country

    10. Europe Central Lab Market Analysis and Forecast

        10.1. Introduction

            10.1.1. Key Findings

        10.2. Market Value Forecast By Product, 2017 - 2031

            10.2.1. Genetic Services

            10.2.2. Biomarker Services

            10.2.3. Microbiology Services

            10.2.4. Anatomic Pathology/Histology

            10.2.5. Specimen Management & Storage

            10.2.6. Special Chemistry Services

            10.2.7. Clinical Research & Trial Services

            10.2.8. Others

        10.3. Market Value Forecast By End-user, 2017 - 2031

            10.3.1. Pharmaceutical Companies

            10.3.2. Biotechnology Companies

            10.3.3. Academic & Research Institutes

        10.4. Market Value Forecast By Country, 2017 - 2031

            10.4.1. Germany

            10.4.2. U.K.

            10.4.3. France

            10.4.4. Spain

            10.4.5. Italy

            10.4.6. Rest of Europe

        10.5. Market Attractiveness Analysis

            10.5.1. By Product

            10.5.2. By End-user

            10.5.3. By Country

    11. Asia Pacific Central Lab Market Analysis and Forecast

        11.1. Introduction

            11.1.1. Key Findings

        11.2. Market Value Forecast By Product, 2017 - 2031

            11.2.1. Genetic Services

            11.2.2. Biomarker Services

            11.2.3. Microbiology Services

            11.2.4. Anatomic Pathology/Histology

            11.2.5. Specimen Management & Storage

            11.2.6. Special Chemistry Services

            11.2.7. Clinical Research & Trial Services

            11.2.8. Others

        11.3. Market Value Forecast By End-user, 2017 - 2031

            11.3.1. Pharmaceutical Companies

            11.3.2. Biotechnology Companies

            11.3.3. Academic & Research Institutes

        11.4. Market Value Forecast By Country, 2017 - 2031

            11.4.1. China

            11.4.2. Japan

            11.4.3. India

            11.4.4. Australia & New Zealand

            11.4.5. Rest of Asia Pacific

        11.5. Market Attractiveness Analysis

            11.5.1. By Product

            11.5.2. By End-user

            11.5.3. By Country

    12. Latin America Central Lab Market Analysis and Forecast

        12.1. Introduction

            12.1.1. Key Findings

        12.2. Market Value Forecast By Product, 2017 - 2031

            12.2.1. Genetic Services

            12.2.2. Biomarker Services

            12.2.3. Microbiology Services

            12.2.4. Anatomic Pathology/Histology

            12.2.5. Specimen Management & Storage

            12.2.6. Special Chemistry Services

            12.2.7. Clinical Research & Trial Services

            12.2.8. Others

        12.3. Market Value Forecast By End-user, 2017 - 2031

            12.3.1. Pharmaceutical Companies

            12.3.2. Biotechnology Companies

            12.3.3. Academic & Research Institutes

        12.4. Market Value Forecast By Country, 2017 - 2031

            12.4.1. Brazil

            12.4.2. Mexico

            12.4.3. Rest of Latin America

        12.5. Market Attractiveness Analysis

            12.5.1. By Product

            12.5.2. By End-user

            12.5.3. By Country

    13. Middle East & Africa Central Lab Market Analysis and Forecast

        13.1. Introduction

            13.1.1. Key Findings

        13.2. Market Value Forecast By Product, 2017 - 2031

            13.2.1. Genetic Services

            13.2.2. Biomarker Services

            13.2.3. Microbiology Services

            13.2.4. Anatomic Pathology/Histology

            13.2.5. Specimen Management & Storage

            13.2.6. Special Chemistry Services

            13.2.7. Clinical Research & Trial Services

            13.2.8. Others

        13.3. Market Value Forecast By End-user, 2017 - 2031

            13.3.1. Pharmaceutical Companies

            13.3.2. Biotechnology Companies

            13.3.3. Academic & Research Institutes

        13.4. Market Value Forecast By Country, 2017 - 2031

            13.4.1. GCC Countries

            13.4.2. South Africa

            13.4.3. Rest of Middle East & Africa

        13.5. Market Attractiveness Analysis

            13.5.1. By Product

            13.5.2. By End-user

            13.5.3. By Country

    14. Competition Landscape

        14.1. Market Player - Competition Matrix (By Tier and Size of companies)

        14.2. Market Share Analysis By Company (2022)

        14.3. Company Profiles

            14.3.1. ACM Global Laboratories

                14.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)

                14.3.1.2. Test Type Portfolio

                14.3.1.3. Financial Overview

                14.3.1.4. SWOT Analysis

                14.3.1.5. Strategic Overview

            14.3.2. Barc Lab (Cerba Research)

                14.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)

                14.3.2.2. Test Type Portfolio

                14.3.2.3. Financial Overview

                14.3.2.4. SWOT Analysis

                14.3.2.5. Strategic Overview

            14.3.3. Bioscientia (Sonic Healthcare)

                14.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)

                14.3.3.2. Test Type Portfolio

                14.3.3.3. Financial Overview

                14.3.3.4. SWOT Analysis

                14.3.3.5. Strategic Overview

            14.3.4. Celerion

                14.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)

                14.3.4.2. Test Type Portfolio

                14.3.4.3. Financial Overview

                14.3.4.4. SWOT Analysis

                14.3.4.5. Strategic Overview

            14.3.5. CIRION BioPharma Research

                14.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)

                14.3.5.2. Test Type Portfolio

                14.3.5.3. Financial Overview

                14.3.5.4. SWOT Analysis

                14.3.5.5. Strategic Overview

            14.3.6. Clinical Reference Laboratory

                14.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)

                14.3.6.2. Test Type Portfolio

                14.3.6.3. Financial Overview

                14.3.6.4. SWOT Analysis

                14.3.6.5. Strategic Overview

            14.3.7. Eurofins Central Laboratory

                14.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)

                14.3.7.2. Test Type Portfolio

                14.3.7.3. Financial Overview

                14.3.7.4. SWOT Analysis

                14.3.7.5. Strategic Overview

            14.3.8. Frontage Laboratories, Inc.

                14.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)

                14.3.8.2. Test Type Portfolio

                14.3.8.3. Financial Overview

                14.3.8.4. SWOT Analysis

                14.3.8.5. Strategic Overview

            14.3.9. ICON Central Laboratories

                14.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)

                14.3.9.2. Test Type Portfolio

                14.3.9.3. Financial Overview

                14.3.9.4. SWOT Analysis

                14.3.9.5. Strategic Overview

            14.3.10. INTERLAB Central Lab Services

                14.3.10.1. Company Overview (HQ, Business Segments, Employee Strength)

                14.3.10.2. Test Type Portfolio

                14.3.10.3. Financial Overview

                14.3.10.4. SWOT Analysis

                14.3.10.5. Strategic Overview

            14.3.11. InVitro International

                14.3.11.1. Company Overview (HQ, Business Segments, Employee Strength)

                14.3.11.2. Test Type Portfolio

                14.3.11.3. Financial Overview

                14.3.11.4. SWOT Analysis

                14.3.11.5. Strategic Overview

            14.3.12. Labcorp/Covance

                14.3.12.1. Company Overview (HQ, Business Segments, Employee Strength)

                14.3.12.2. Test Type Portfolio

                14.3.12.3. Financial Overview

                14.3.12.4. SWOT Analysis

                14.3.12.5. Strategic Overview

            14.3.13. LabConnect

                14.3.13.1. Company Overview (HQ, Business Segments, Employee Strength)

                14.3.13.2. Test Type Portfolio

                14.3.13.3. Financial Overview

                14.3.13.4. SWOT Analysis

                14.3.13.5. Strategic Overview

            14.3.14. Medpace

                14.3.14.1. Company Overview (HQ, Business Segments, Employee Strength)

                14.3.14.2. Test Type Portfolio

                14.3.14.3. Financial Overview

                14.3.14.4. SWOT Analysis

                14.3.14.5. Strategic Overview

            14.3.15. MLM Medical Labs GmbH

                14.3.15.1. Company Overview (HQ, Business Segments, Employee Strength)

                14.3.15.2. Test Type Portfolio

                14.3.15.3. Financial Overview

                14.3.15.4. SWOT Analysis

                14.3.15.5. Strategic Overview

            14.3.16. PPD

                14.3.16.1. Company Overview (HQ, Business Segments, Employee Strength)

                14.3.16.2. Test Type Portfolio

                14.3.16.3. Financial Overview

                14.3.16.4. SWOT Analysis

                14.3.16.5. Strategic Overview

            14.3.17. Q² Solutions

                14.3.17.1. Company Overview (HQ, Business Segments, Employee Strength)

                14.3.17.2. Test Type Portfolio

                14.3.17.3. Financial Overview

                14.3.17.4. SWOT Analysis

                14.3.17.5. Strategic Overview

    List of Tables

    Table 01: Global Central Lab Market Value (US$ Mn) Forecast, by Product, 2017-2031

    Table 02: Global Central Lab Market Value (US$ Mn) Forecast, by End-user, 2017‒2031

    Table 03: Global Central Lab Market Value (US$ Mn) Forecast, by Region, 2017-2031

    Table 04: North America Central Lab Market Value (US$ Mn) Forecast, by Country, 2017-2031

    Table 05: North America Central Lab Market Value (US$ Mn) Forecast, by Product, 2017-2031

    Table 06: North America Central Lab Market Value (US$ Mn) Forecast, by End-user, 2017‒2031

    Table 07: Europe Central Lab Market Value (US$ Mn) Forecast, by Country/Sub-Region, 2017-2031

    Table 08: Europe Central Lab Market Value (US$ Mn) Forecast, by Product, 2017-2031

    Table 09: Europe Central Lab Market Value (US$ Mn) Forecast, by End-user, 2017‒2031

    Table 10: Asia Pacific Central Lab Market Value (US$ Mn) Forecast, by Country/Sub-Region, 2017-2031

    Table 11: Asia Pacific Central Lab Market Value (US$ Mn) Forecast, by Product, 2017-2031

    Table 12: Asia Pacific Central Lab Market Value (US$ Mn) Forecast, by End-user, 2017‒2031

    Table 13: Latin America Central Lab Market Value (US$ Mn) Forecast, by Country/Sub-Region, 2017-2031

    Table 14: Latin America Central Lab Market Value (US$ Mn) Forecast, by Product, 2017-2031

    Table 15: Latin America Central Lab Market Value (US$ Mn) Forecast, by End-user, 2017‒2031

    Table 16: Middle East & Africa Central Lab Market Value (US$ Mn) Forecast, by Country/Sub-Region, 2017-2031

    Table 17: Middle East & Africa Central Lab Market Value (US$ Mn) Forecast, by Product, 2017-2031

    Table 18: Middle East & Africa Central Lab Market Value (US$ Mn) Forecast, by End-user, 2017‒2031

    List of Figures

    Figure 01: Global Central Lab market Value (US$ Mn) Forecast, 2017-2031

    Figure 02: Global Central Lab market Value Share, by Product, 2022

    Figure 03: Global Central Lab market Value Share, by End-user, 2022

    Figure 04: Global Central Lab market Value Share, by Region, 2022

    Figure 05: Global Central Lab Market Value Share Analysis, by Product, 2022 and 2031

    Figure 06: Global Central Lab Market Attractiveness Analysis, by Product, 2023-2031

    Figure 07: Global Central Lab Market Revenue (US$ Mn), by Genetic Services, 2017-2031

    Figure 08: Global Central Lab Market Revenue (US$ Mn), by Biomarker Services, 2017-2031

    Figure 09: Global Central Lab Market Revenue (US$ Mn), by Microbiology Services, 2017-2031

    Figure 10: Global Central Lab Market Revenue (US$ Mn), by Anatomic Pathology/Histology, 2017-2031

    Figure 11: Global Central Lab Market Revenue (US$ Mn), by Specimen Management & Storage, 2017-2031

    Figure 12: Global Central Lab Market Revenue (US$ Mn), by Special Chemistry Services, 2017-2031

    Figure 13: Global Central Lab Market Revenue (US$ Mn), by Clinical Research & Trial Services, 2017-2031

    Figure 14: Global Central Lab Market Revenue (US$ Mn), by Others, 2017-2031

    Figure 15: Global Central Lab Market, by End-user, 2022 and 2031

    Figure 16: Global Central Lab Market, by End-user, 2023-2031

    Figure 17: Global Central Lab Market Revenue (US$ Mn), by Pharmaceutical Companies, 2017-2031

    Figure 18: Global Central Lab Market Revenue (US$ Mn), by Biotechnology Companies, 2017-2031

    Figure 19: Global Central Lab Market Revenue (US$ Mn), by Academic & Research Institutes, 2017-2031

    Figure 20: Global Central Lab Market Value Share Analysis, by Region, 2022 and 2031

    Figure 21: Global Central Lab Market Attractiveness Analysis, by Region, 2023-2031

    Figure 22: North America Central Lab Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017-2031

    Figure 23: North America Central Lab Market Value Share Analysis, by Country, 2022 and 2031

    Figure 24: North America Central Lab Market Attractiveness Analysis, by Country, 2023-2031

    Figure 25: North America Central Lab Market Value Share Analysis, by Product, 2022 and 2031

    Figure 26: North America Central Lab Market Attractiveness Analysis, by Product, 2023-2031

    Figure 27: North America Central Lab Market, by End-user, 2022 and 2031

    Figure 28: North America Central Lab Market, by End-user, 2023-2031

    Figure 29: Europe Central Lab Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017-2031

    Figure 30: Europe Central Lab Market Value Share Analysis, by Country, 2022 and 2031

    Figure 31: Europe Central Lab Market Attractiveness Analysis, by Country, 2023-2031

    Figure 32: Europe Central Lab Market Value Share Analysis, by Product, 2022 and 2031

    Figure 33: Europe Central Lab Market Attractiveness Analysis, by Product, 2023-2031

    Figure 34: Europe Central Lab Market, by End-user, 2022 and 2031

    Figure 35: Europe Central Lab Market, by End-user, 2023-2031

    Figure 36: Asia Pacific Central Lab Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017-2031

    Figure 37: Asia Pacific Central Lab Market Value Share Analysis, by Country, 2022 and 2031

    Figure 38: Asia Pacific Central Lab Market Attractiveness Analysis, by Country,

    Figure 39: Asia Pacific Central Lab Market Value Share Analysis, by Product, 2022 and 2031

    Figure 40: Asia Pacific Central Lab Market Attractiveness Analysis, by Product, 2023-2031

    Figure 41: Asia Pacific Central Lab Market, by End-user, 2022 and 2031

    Figure 42: Asia Pacific Central Lab Market, by End-user, 2023-2031

    Figure 43: Latin America Central Lab Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017-2031

    Figure 44: Latin America Central Lab Market Value Share Analysis, by Country, 2022 and 2031

    Figure 45: Latin America Central Lab Market Attractiveness Analysis, by Country, 2023-2031

    Figure 46: Latin America Central Lab Market Value Share Analysis, by Product, 2022 and 2031

    Figure 47: Latin America Central Lab Market Attractiveness Analysis, by Product, 2023-2031

    Figure 48: Latin America Central Lab Market, by End-user, 2022 and 2031

    Figure 49: Latin America Central Lab Market, by End-user, 2023-2031

    Figure 50: Middle East & Africa Central Lab Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017-2031

    Figure 51: Middle East & Africa Central Lab Market Value Share Analysis, by Country, 2022 and 2031

    Figure 52: Middle East & Africa Central Lab Market Attractiveness Analysis, by Country, 2023-2031

    Figure 53: Middle East & Africa Central Lab Market Value Share Analysis, by Product, 2022 and 2031

    Figure 54: Middle East & Africa Central Lab Market Attractiveness Analysis, by Product, 2023-2031

    Figure 55: Middle East & Africa Central Lab Market, by End-user, 2022 and 2031

    Figure 56: Middle East & Africa Central Lab Market, by End-user, 2023-2031

    Figure 57: Global Central Lab Market Share, by Company, 2022

Copyright © Transparency Market Research, Inc. All Rights reserved